Nine Anticipated FDA Approvals for January 2026 Guideline Central DIHEXA PEPTIDE 10MG VIAL UMBRELLA Labs A federal review is underway that could reclassify 14 peptides into FDA Category 1. This change that may influence how peptide therapies are accessed in the U.S. Here's what experts are EllieMD Dihexa What is dihexa, its mechanism of action via the HGF c Met pathway, and its safety and clinical use? FDA Announces Change in Status of 12 Peptides SSRP Institute